Amarin Corp Plcuk (AMRN) Retained Earnings (2010 - 2026)
Amarin Corp Plc\Uk (AMRN) posted quarterly Retained Earnings of $1.9 billion for Q2 2026, little changed year-over-year from $1.9 billion in Q2 2025, and little changed quarter-over-quarter from $1.9 billion in Q1 2026.
Amarin Corp Plcuk (AMRN) Retained Earnings (2010 - 2026) Analysis & Trends
Amarin Corp Plc\Uk (AMRN) has reported Retained Earnings for 17 consecutive years, with $1.9 billion the latest figure, recorded in Q2 2026.
- In Q2 2026, Retained Earnings changed 0.15% year-over-year to $1.9 billion; the TTM figure through Jun 2026 stood at $1.9 billion (changed 0.15% YoY), while the FY2025 annual figure was $1.9 billion, changed 0.47% from the prior year.
- Retained Earnings was little changed at $1.9 billion in Q2 2026 per AMRN's latest filing, from $1.9 billion in the prior quarter.
- Across five years, Retained Earnings topped out at $1.9 billion in Q2 2026 and bottomed at $1.9 billion in Q1 2022.
- Historically, Retained Earnings has averaged $1.9 billion across 5 years, with a median of $1.9 billion in 2024.
- Annual changes were most pronounced in 2022 — Retained Earnings climbed 1.92% — and 2026, when it gained 0.15%.
- Amarin Corp Plc\Uk's Retained Earnings stood at $1.9 billion in 2022, then increased by 0.75% to $1.9 billion in 2023, then grew by 0.81% to $1.9 billion in 2024, then gained by 0.47% to $1.9 billion in 2025, then increased by 0.0% to $1.9 billion in 2026.
- Business Quant data shows AMRN's Retained Earnings at $1.9 billion in Q2 2026, $1.9 billion in Q1 2026, and $1.9 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.90 Bn | 633.14 Bn | 17.26 Bn | 171.67 Bn |
| 2 | AbbVie | 470.19 Bn | 463.62 Bn | 12.70 Bn | -17.33 Bn |
| 3 | Merck | 377.19 Bn | 370.05 Bn | 12.21 Bn | 63.27 Bn |
| 4 | Novartis Ag | 303.28 Bn | 295.59 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.67 Bn | 252.77 Bn | 12.86 Bn | 12.59 Bn |
| 6 | Amgen | 236.95 Bn | 222.96 Bn | 7.24 Bn | -22.28 Bn |
| 7 | Gilead Sciences | 182.20 Bn | 179.02 Bn | 6.22 Bn | 9.53 Bn |
| 8 | Pfizer | 159.32 Bn | 147.62 Bn | 10.94 Bn | 112.09 Bn |
| 9 | Gsk | 106.10 Bn | 101.93 Bn | 8.24 Bn | 15.38 Bn |
| 10 | Amarin Corp Plcuk | 5.87 Bn | 5.56 Bn | 14.99 Mn | 1.92 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.92 Bn |
| Mar 31, 2026 | 1.92 Bn |
| Dec 31, 2025 | 1.92 Bn |
| Sep 30, 2025 | 1.92 Bn |
| Jun 30, 2025 | 1.92 Bn |
| Mar 31, 2025 | 1.92 Bn |
| Dec 31, 2024 | 1.91 Bn |
| Sep 30, 2024 | 1.91 Bn |
| Jun 30, 2024 | 1.91 Bn |
| Mar 31, 2024 | 1.90 Bn |
| Dec 31, 2023 | 1.90 Bn |
| Sep 30, 2023 | 1.90 Bn |
| Jun 30, 2023 | 1.89 Bn |
| Mar 31, 2023 | 1.89 Bn |
| Dec 31, 2022 | 1.89 Bn |
| Sep 30, 2022 | 1.88 Bn |
| Jun 30, 2022 | 1.87 Bn |
| Mar 31, 2022 | 1.86 Bn |
| Dec 31, 2021 | 1.86 Bn |
| Sep 30, 2021 | 1.85 Bn |